Company research
Omega Therapeutics, Inc.
CIK 1850838Updated Nov 16, 2026
Securities
Historical securities (2)
OMGAQ · OTC · equity · closed Aug 11, 2025OMGAQ · OTC · equity · closed Aug 11, 2025OMGAQ price & chart
Historical security
This listing closed Aug 11, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 204,366,000Source | 145,998,000Source | 233,333,000Source | 28,083,000Source |
| Property, Plant and Equipment, NetUSD | 5,311,000Source | 4,195,000Source | 3,605,000Source | 3,482,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 68,443,000Source | 70,615,000Source | 186,482,000Source | 22,951,000Source |
| Accounts Receivable | — | — | — | — |
| Assets, CurrentUSD | 89,884,000Source | 137,590,000Source | 229,286,000Source | 24,003,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 10,324,000Source | 12,294,000Source | 3,702,000Source | 1,052,000Source |
| Operating Lease, Right-of-Use AssetUSD | 108,736,000Source | 3,668,000Source | — | — |
| Other Assets, NoncurrentUSD | 94,000Source | 204,000Source | 101,000Source | 257,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 146,350,000Source | 40,027,000Source | 32,705,000Source | 17,486,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 55,000Source | 48,000Source | 48,000Source | 5,000Source |
| Additional Paid in CapitalUSD | 392,609,000Source | 343,608,000Source | 335,147,000Source | 1,592,000Source |
| Retained Earnings (Accumulated Deficit)USD | -334,634,000Source | -237,206,000Source | -134,505,000Source | -66,225,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -14,000Source | -479,000Source | -62,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 58,016,000Source | 105,971,000Source | 200,628,000Source | -64,628,000Source |
| Liabilities and EquityUSD | 204,366,000Source | 145,998,000Source | 233,333,000Source | 28,083,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 26,806,000Source | 21,964,000Source | 11,983,000Source | 7,699,000Source |
| Operating Lease, Liability, CurrentUSD | 11,300,000Source | 1,524,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,620,000Source | 3,107,000Source | 2,109,000Source | 1,063,000Source |
| Operating Lease, Liability, NoncurrentUSD | 98,243,000Source | 1,120,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 6,416,000Source | 340,000Source | 853,000Source | 1,055,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 7,914,000Source | 13,841,000Source | 9,475,000Source | 3,277,000Source |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | 0Source | 0Source | 0Source | — |
| Deferred Tax Liabilities, NetUSD | 29,747,000Source | 1,196,000Source | 188,000Source | 242,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 19,869,000Source | — |
| Long-term Debt, Current MaturitiesUSD | 4,000,000Source | 3,333,000Source | — | 3,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 14,885,000Source | 16,603,000Source | 19,869,000Source | 8,732,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -97,428,000Source | -102,701,000Source | -68,280,000Source | -29,447,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 8,793,000Source | 7,753,000Source | 3,184,000Source | 637,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 5,125,000Source | — | — | — |
| Increase (Decrease) in Accounts PayableUSD | -1,487,000Source | 985,000Source | 1,040,000Source | 138,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -91,510,000Source | -98,515,000Source | -57,609,000Source | -26,133,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 47,515,000Source | -18,060,000Source | -40,399,000Source | -1,808,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 2,869,000Source | 1,380,000Source | 1,467,000Source | 1,808,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 41,823,000Source | 708,000Source | 261,539,000Source | 48,618,000Source |
| Repayments of Long-term DebtUSD | 1,000,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -2,172,000Source | -115,867,000Source | 163,531,000Source | 20,677,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,723,000Source | 1,263,000Source | 754,000Source | 732,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 8,793,000Source | 7,753,000Source | 3,184,000Source | 637,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 53,000Source | 67,000Source | 93,000Source | 48,000Source |
| DepreciationUSD | 1,568,000Source | 1,564,000Source | 1,387,000Source | 1,146,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 233,000Source | — | 3,000Source | -28,000Source |
| General and Administrative ExpenseUSD | 26,186,000Source | 21,821,000Source | 16,603,000Source | 6,236,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -97,428,000Source | -102,701,000Source | -68,280,000Source | -29,447,000Source |
| Nonoperating Income (Expense)USD | 2,833,000Source | 65,000Source | -2,248,000Source | -802,000Source |
| Operating ExpensesUSD | 103,355,000Source | 104,839,000Source | 66,176,000Source | 28,645,000Source |
| Operating Lease, ExpenseUSD | — | — | 3,300,000Source | 2,200,000Source |
| Other Nonoperating Income (Expense)USD | 23,000Source | -157,000Source | -28,000Source | -28,000Source |
| Payments of Financing CostsUSD | 15,000Source | — | 15,000Source | — |
| Proceeds from Issuance of Common StockUSD | 488,000Source | — | — | — |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 69,502,000Source | 40,735,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | 708,000Source | 274,000Source | 101,000Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | — | — | 144,000Source | — |
| Operating Income (Loss)USD | -100,261,000Source | -102,766,000Source | -66,032,000Source | -28,645,000Source |
| Other Nonoperating Income (Expense)USD | 23,000Source | -157,000Source | -28,000Source | -28,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -97,428,000Source | -102,701,000Source | -68,280,000Source | -29,447,000Source |
| Earnings Per Share, BasicUSD per share | -1.8Source | -2.14Source | — | — |
| Earnings Per Share, DilutedUSD per share | -1.8Source | -2.14Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 54,010,996Source | 47,880,819Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 54,010,996Source | 47,880,819Source | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 26,186,000Source | 21,821,000Source | 16,603,000Source | 6,236,000Source |
| Interest ExpenseUSD | — | — | 910,000Source | 777,000Source |
| Interest Expense, DebtUSD | 1,801,000Source | 1,296,000Source | 998,000Source | 780,000Source |
| Interest Income (Expense), NetUSD | 2,810,000Source | 222,000Source | — | — |
| Nonoperating Income (Expense)USD | 2,833,000Source | 65,000Source | -2,248,000Source | -802,000Source |
| Operating ExpensesUSD | 103,355,000Source | 104,839,000Source | 66,176,000Source | 28,645,000Source |
| Operating Lease, ExpenseUSD | — | — | 3,300,000Source | 2,200,000Source |
| Research and Development ExpenseUSD | 77,169,000Source | 79,996,000Source | 47,865,000Source | 21,063,000Source |